SRPT

Sarepta Therapeutics, Inc.

Biotechnology · Biotechnology

$202.77 sample

-0.22 (-0.11%) 1D

Market cap

$347.0B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-22

Alerts

8

Price$202.77 +9.18% 3M daily closessample

207.33181.28

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Director
Sep 22SEC10-Q filed
Sep 15SEC8-K filed: material event
Sep 08SEC10-Q filed
Aug 28SECForm 144 filed
Aug 24INSInsider sell: 10% owner
Aug 18SECDEF 14A filed
Aug 07INSInsider sell: Director

Sign up to see the real SRPT record →

Company facts

SEC EDGAR registration

Name: Sarepta Therapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -26sample, -100 to +100
Reporting currency: USD

Who is positioning in SRPT

sample

Insiders: 14 insider transactions over 90 days, net selling, $665.4M
Congress: 3 members traded over 90 days
Institutions · 13F: 40 funds hold $5.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.4B +13.9% y/y

Q4 2024Q3 2026

Inventory$10.6B +8.6% y/y

Q4 2024Q3 2026

Accounts receivable$8.2B +11.4% y/y

Q4 2024Q3 2026

Total debt$22.1B +17.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $274.9B -11.5% 3M
Sample peer B: $229.6B -9.4% 3M
Sample peer C: $279.3B +13.1% 3M
Sample peer D: $320.4B +6.0% 3M
Sample peer E: $53.1B -12.8% 3M